Litigation Details for Pfizer Inc. v. Apotex Inc. (D. Del. 2021)
✉ Email this page to a colleague
Pfizer Inc. v. Apotex Inc. (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-09-30 |
| Court | District Court, D. Delaware | Date Terminated | 2021-10-19 |
| Cause | 35:1 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 6,890,927; 7,265,119 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pfizer Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Pfizer Inc. v. Apotex Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-09-30 | 1 | Complaint | expiration of the U.S. Patent Nos. 6,890,927 (the “’927 patent”) and 7,265,119 (the “’119 patent”), which cover… COUNT I – INFRINGEMENT OF U.S. PATENT 6,890,927 28. Plaintiffs reallege and incorporate… b. That Apotex has infringed U.S. Patent Nos. 6,890,927 and 7,265,119; c. That, pursuant…. This is a civil action for patent infringement under the patent laws of the United States, Title… PATENTS-IN-SUIT 9. On May 10, 2005, the United States Patent and Trademark | External link to document |
| 2021-09-30 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,890,927 B2 ;7,265,119 B2. (…2021 19 October 2021 1:21-cv-01402 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-10-19 | 9 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,890,927 B2; 7,265,119 B2. (…2021 19 October 2021 1:21-cv-01402 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
